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Dorsal horn neurons process
somatosensory information, including
pain. Inquimbert et al. utilized spatially
restricted Grin1 knockout to show that
NMDA-receptor-mediated excitatory
input causes the degeneration of some
dorsal horn neurons after nerve injury.
Irreversible loss of GABAergic
interneurons leads to a deficit in inhibition
that promotes persistent pain
hypersensitivity.
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Peripheral nerve lesions provoke apoptosis in the
dorsal horn of the spinal cord. The cause of cell
death, the involvement of neurons, and the relevance
for the processing of somatosensory information are
controversial. Here, we demonstrate in a mouse
model of sciatic nerve injury that glutamate-induced
neurodegeneration and loss of g-aminobutyric acid
(GABA)ergic interneurons in the superficial dorsal
horn promote the transition from acute to chronic
neuropathic pain. Conditional deletion of Grin1,
the essential subunit of N-methyl-D-aspartate-
type glutamate receptors (NMDARs), protects dorsal
horn neurons from excitotoxicity and preserves
GABAergic inhibition. Mice deficient in functional
NMDARs exhibit normal nociceptive responses and
acute pain after nerve injury, but this initial increase
in pain sensitivity is reversible. Eliminating NMDARs
fully prevents persistent pain-like behavior. Reduced
pain in mice lacking proapoptotic Bax confirmed the
significance of neurodegeneration. We conclude that
NMDAR-mediated neuron death contributes to the
development of chronic neuropathic pain.
INTRODUCTION
A key characteristic of pain caused by a lesion or disease of the
nervous system (neuropathic pain) is its persistence (Colloca
et al., 2017). Preclinical studies have revealed that multiple mo-
lecular changes in primary sensory neurons, plasticity of central2678 Cell Reports 23, 2678–2689, May 29, 2018 ª 2018 The Authors
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contribute to the development of neuropathic pain (von Hehn
et al., 2012). Many of these investigations focus on the onset
of pain during the first one or two weeks following nerve injury.
It is increasingly clear though that the involvement of individual
pain mechanisms changes with time. Microglia, for example,
promote the onset of neuropathic pain through cytokine and
growth factor release in the spinal cord (Peng et al., 2016). In
contrast, astrocytes respond to nerve injury with a delay of
several days or weeks and appear to support the maintenance
of pain rather than its initial development (Ji et al., 2014; Scholz
and Woolf, 2007). Although insight into the short- and long-term
changes of the nociceptive system after nerve injury has
improved, the mechanisms driving the transition from acute to
chronic pain remain to be resolved.
One process potentially linked to the emergence of persistent
pain is the apoptosis of dorsal horn neurons. A loss of dorsal horn
neurons after nerve injury has been found in independent studies
(Yowtak et al., 2013; Scholz et al., 2005). Conflicting reports may
be explained by inadequate statistical power because they relied
on the analysis of a single section per spinal cord and an uncon-
ventional stereological design that has not been validated (Pol-
ga´r et al., 2004, 2005). However, the mechanisms responsible
for the induction of apoptosis are unknown and its functional sig-
nificance has been disputed (Polga´r et al., 2005). Clarifying the
etiology and relevance of nerve-injury-induced neurodegenera-
tion is essential because neuroprotection may offer a disease-
modifying treatment strategy for neuropathic pain.
We have previously shown that afferent input from the injured
nerve promotes the apoptosis induction (Scholz et al., 2005). The
major transmitter of primary sensory neurons at central nocicep-
tive synapses of the dorsal horn is glutamate. Postsynaptic
insertion of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic.
creativecommons.org/licenses/by-nc-nd/4.0/).
acid-type glutamate receptors (AMPARs), voltage-dependent
recruitment of N-methyl-D-aspartate receptors (NMDARs), and
changes in the composition of postsynaptic densities strengthen
glutamatergic transmission following a nerve lesion (Kuner,
2010; Latremoliere and Woolf, 2009). Activation of NMDARs is
critical for this process of central sensitization because it leads
to enhanced Ca2+ influx and the engagement of intracellular
signaling pathways that amplify the response to nociceptive
input. However, excess Ca2+ increases may cause neuron
death, and extrasynaptic NMDAR activation may suppress sur-
vival-promoting genes (Hara and Snyder, 2007; Hardingham
et al., 2002). To test whether nerve injury produces an excitotoxic
challenge in the spinal cord, we selectively eliminated NMDARs
in dorsal horn neurons of adult mice. Unlike pharmacological in-
hibition, this targeted genetic approach did not interfere with
presynaptic glutamatergic transmission or NMDAR activity in
supraspinal pathways. We found that the conditional deletion
of NMDARs at dorsal horn synapses provided effective neuro-
protection and blocked the transition from acute to persistent
neuropathic-pain-like behavior without affecting physiological
nociception. Mice lacking proapoptotic Bcl2-associated X
(Bax) showed a similar reduction of chronic pain after nerve
injury, confirming the functional impact of neurodegeneration.
RESULTS
Eliminating Functional NMDARsAbolishes Nerve-Injury-
Induced Apoptosis
Weexamined the induction of apoptosis after spared nerve injury
(SNI), a partial sciatic nerve lesion associated with persistent
pain hypersensitivity in rodents (Figure 1A; Decosterd andWoolf,
2000). Terminal deoxynucleotidyl transferase dUTP nick end la-
beling (TUNEL) revealed cell profiles with chromatin changes
indicative of apoptosis in the dorsal horn of C57BL/6 mice
7 days after SNI (Figure 1B). Most of these profiles were located
in themedial dorsal horn of spinal cord segment L4 (Figure 1C), in
a distribution corresponding to the central projections of the
lesioned common peroneal and tibial branches of the sciatic
nerve (Corder et al., 2010). Apoptosis induction continued for
2 weeks and was limited to the ipsilateral dorsal horn (Figures
1D and 1E).
To test the involvement of NMDAR-mediated glutamatergic
transmission, we utilized transgenic mice with a floxed sequence
of the Grin1 gene (Tsien et al., 1996). Grin1 encodes NMDAR
subunit GluN1, which is required for the assembly of functional
receptors. Stereotaxic injection of an adeno-associated virus
(AAV8) with a plasmid encoding a fusion protein of Cre recombi-
nase and GFP eliminated Grin1 expression and NMDAR activity
in the spinal cord within 2 or 3 weeks (Figures 1F, 1G, and S1A).
The loss of NMDAR-mediated transmission was a direct result of
transgene recombination and not related to AAV8 infection or
GFP expression. NMDA-evoked currents in Grin1flox/flox mice in-
jected with a GFP-encoding control vector did not differ from
those in uninjured C57BL/6 mice or C57BL/6 mice after SNI (Fig-
ure 1G). To examine the effect of conditional Grin1 deletion on
apoptosis induction, we first injected Grin1flox/flox mice with
AAV8-GFP-Cre and waited 3 weeks to ensure complete recom-
bination before performing SNI. Seven days after the nervelesion, we found that apoptotic profiles in the dorsal horn were
markedly reduced compared to mice injected with the control
vector AAV8-GFP (Figure 1H).
Grin1 Deletion Prevents Neuron Loss
AAV8 infection andCre expression were restricted to dorsal horn
neurons (Figures S1B–S1F). To examine the efficacy of neuro-
protection provided by NMDAR elimination, we conducted a ste-
reological analysis of neuron survival. Because apoptosis induc-
tion was concentrated within the distribution of central terminals
of the injured sciatic nerve branches, we counted neurons immu-
nostained for neuronal nuclei protein (NeuN) in the medial half of
the dorsal horn. We performed these counts 4 weeks after SNI,
assuming that neurodegeneration would be complete at this
time. SNI led to a decrease in the number of dorsal horn neurons
by 25% (95% confidence interval [CI] 16%–35%; p < 0.001) in
laminae I+II and 14% (95% confidence interval 4.1%–24%; p <
0.01) in laminae III+IV (Figures 2A and 2B). Grin1flox/flox mice in-
jected with AAV8-GFP-Cre were fully protected against the
loss of neurons. The number of dorsal horn neurons in these
mice after SNI did not differ from that in uninjured C57BL/6
mice. In contrast, neurons in Grin1flox/flox mice injected with the
control vector AAV8-GFP were reduced by 19% in both laminae
I+II (95% CI 4.4%–34%; p < 0.05) and laminae III+IV (95% CI
2.6%–36%; p < 0.05; Figures 2C and 2D).
NMDAR-Mediated Neuron Death Impairs Spinal
Inhibition
g-aminobutyric acid (GABA)ergic and glycinergic inhibition is
essential for the processing of nociceptive information (Peirs
and Seal, 2016). Pharmacological blockade of inhibitory signal
transmission, experimental ablation, or silencing of inhibitory
dorsal horn neurons provoke spontaneous pain-like behavior
and exaggerated reactions to painful stimuli (Cui et al., 2016;
Foster et al., 2015; Petitjean et al., 2015; Duan et al., 2014;
Lu et al., 2013). Whether nerve-injury-induced neurodegenera-
tion in the dorsal horn involves inhibitory neurons is controver-
sial (Yowtak et al., 2013; Scholz et al., 2005; Polga´r et al.,
2003).
To address this issue, we first determined whether SNI caused
a decrease in GABAergic neurons. For this purpose, we used
mice that express GFP under the promotor for glutamate decar-
boxylase 1 (Gad1), a marker of GABAergic neurons (Figure 3A;
Tamamaki et al., 2003). Four weeks after SNI, we found
GABAergic neurons in laminae I+II of the L4 spinal cord reduced
by 10% (95% CI 0.4%–20%; p < 0.05). The number of
GABAergic neurons in laminae III+IV did not change (Figure 3B).
Lamina III and lower contain the majority of glycinergic dorsal
horn neurons. Most of these neurons are also GABAergic, but
those that produce glycine only would not be fluorescently
labeled in Gad1-GFP mice (Zeilhofer et al., 2012). To account
for these neurons, we utilized mice that express the yellow fluo-
rescent protein Venus under the promoter for vesicular inhibitory
amino acid transporter (Viaat), a marker of both GABAergic and
glycinergic neurons (Figure 3C; Wang et al., 2009). Stereological
analysis of neurons expressing Venus confirmed that the number
of inhibitory neurons in laminae III+IV did not decline after SNI





Figure 1. NMDAR-Mediated Glutamatergic
Transmission Causes Nerve-Injury-Induced
Apoptosis
(A) Schematic illustration of SNI and the relevant
neuroanatomy. DRG, dorsal root ganglion.
(B) Apoptotic cell profiles 7 days after SNI.
H33342, Hoechst 33342 (bisbenzimide). Scale
bar, 10 mm.
(C) Distribution of apoptotic profiles within the
dorsal horn, shown in overlays of 10 sections per
mouse (n = 8 mice).
(D) Time course of apoptosis induction. Apoptotic
profiles were counted in 10 sections per mouse
(n = 8). p < 0.001 for surgery and time in a two-way
ANOVA. ***p < 0.001 in Sidak’s test following the
ANOVA.
(E) Apoptosis in uninjured mice and the ipsilateral
and contralateral dorsal horns of mice 7 days after
SNI (n = 8). p < 0.001 in a one-way ANOVA. ***p <
0.001 in Dunnett’s test following the ANOVA.
Apoptosis in the white matter was not significantly
different in Student’s t test.
(F and G) Stereotaxic injection of AAV8-GFP-Cre
into the spinal cord of Grin1flox/flox mice eliminated
NMDAR function.
(F) GFP expression (left) and in situ hybridization of
Grin1 mRNA (right) 3 weeks after injection of the
vector into the left dorsal horn of the lumbar (L4)
spinal cord. Scale bars, 100 mm (left) or 200 mm
(right).
(G) Excitatory currents evoked by NMDA (100 mM)
in Grin1flox/flox mice injected with AAV8-GFP or
AAV8-GFP-Cre. SNI was performed 2 or 3 weeks
after the vector injection. Two weeks after the
nerve injury, we compared current amplitudes in
the dorsal horn of mice injected with AAV8-GFP
(n = 5 neurons) or AAV8-GFP-Cre (n = 11). ***p <
0.001 in Student’s t test. Currents recorded in
Grin1flox/flox mice injected with AAV8-GFP did not
differ from those in uninjured C57BL/6 mice (n = 4)
or C57BL/6 mice after SNI (n = 6).
(H) Apoptotic profiles 7 days after SNI in the dorsal
horn of Grin1flox/flox mice injected with AAV8-GFP
or AAV8-GFP-Cre (n = 6 mice). ***p < 0.001 in
Student’s t test.
Error bars indicate SEM. See also Figures S1
and S5.Next, we tested whether neuroprotection by Grin1 deletion
maintained the functional integrity of inhibitory neurons. To this
end, we analyzed miniature inhibitory postsynaptic currents
(mIPSCs) from neurons in lamina II and the border to lamina III
in slices of the L4 spinal cord of C57BL/6 mice. Following SNI,
the frequency ofmIPSCs decreased by 69% (p < 0.001). The cur-
rent amplitude did not change, indicating a presynaptic cause of2680 Cell Reports 23, 2678–2689, May 29, 2018the inhibitory deficit (Figure 3E). Patch-
clamp recordings from the spinal cord
of Grin1flox/flox mice with intact NMDARs
showed a similar low frequency of total
mIPSCs after SNI. However, eliminating
functional NMDARs prevented the loss
of mIPSCs. Frequency and amplitude ofmIPSCs in the dorsal horn of Grin1flox/flox mice injected with
AAV8-GFP-Cre were indistinguishable from currents recorded
in uninjured C57BL/6 mice, demonstrating that Grin1 deletion
preserved spinal inhibition (Figure 3F).
Fast synaptic inhibition in the spinal cord is mediated through
GABAA or glycine receptors (Zeilhofer et al., 2012). For a differen-




Figure 2. Grin1 Deletion Protects against the Loss of Dorsal Horn Neurons
(A) Representative photographs of the L4 dorsal horn of uninjured C57BL/6 mice and 28 days after SNI. Neurons were immunostained for NeuN. Scale bar,
100 mm.
(B) Stereological counts of neurons (NeuN) in laminae I+II and laminae III+IV of the dorsal horn of uninjured mice (n = 6) and after SNI (n = 8).
(C) Representative photographs of the L4 dorsal horn of Grin1flox/flox mice 28 days after SNI. Scale bar, 100 mm.
(D) Stereological counts of neurons in the dorsal horn ofGrin1flox/floxmice injected with AAV8-GFP (n = 6) or AAV8-GFP-Cre (n = 5). Neuronswere counted 28 days
after SNI.
*p < 0.05; **p < 0.01; ***p < 0.001 in Student’s t tests. Error bars indicate SEM. Schematic drawings indicate the counting ROIs (gray). See also Table S1.mIPSCs in the presence of the glycine receptor inhibitor strych-
nine (1 mM) and found that, after SNI, these mIPSCs were
reduced by 56% (p < 0.05). The isolation of GABAergic currents
further revealed a moderate decrease in amplitude by 25% (p <
0.05; Figure 3G).Grin1 deletion protected against the changes in
both frequency (p < 0.01) and amplitude (p < 0.05) of GABAergic
mIPSCs (Figure 3H). Glycinergic mIPSCs, recorded in the pres-
ence of the GABAA receptor antagonist bicuculline (10 mM),
were not affected by the nerve injury, indicating that the inhibitory
deficit after SNI was primarily caused by a loss of GABAergic
currents (Figure 3I).
We also tested whether excitatory currents decreased. How-
ever, neither frequency nor amplitude of miniature excitatory
postsynaptic currents (mEPSCs) recorded from neurons in the
L4 spinal cord of C57BL/6 mice changed after SNI (Figure S2).
The Deficit in Inhibition Is Not Explained by a
Downregulation of GABA Synthesis or Vesicular
Transport
The decrease inmIPSCswas greater than the proportion of inter-
neurons lost after SNI. This may reflect the dense connectivity
and high number of synapses formed by GABAergic neurons
or suggest a deficit in transmitter synthesis and release by sur-
viving interneurons. Gad1 and Gad2 catalyze GABA synthesis,
whereas glycine is primarily recycled from the extracellular
space by glycine transporter 2 (Glyt2). Viaat concentrates both
GABA and glycine in presynaptic vesicles (Zeilhofer et al.,
2012). To determine whether changes in the expression of theseproteins contributed to the loss of inhibition, we used real-time
qPCR and western blotting. Despite the reduced number of
GABAergic neurons after SNI, expression of all four genes in
the ipsilateral dorsal horn remained stable (Figures 4A–4D). To
examine whether gene transcription was upheld by epigenomic
modulation, we used chromatin immunoprecipitation (ChIP) for
acetylated (ac) lysine (K) residues 9 and 27 of histone 3 (H3)
and trimethylated (me3) H3K4. These histone modifications are
commonly associated with active gene transcription (Kouzar-
ides, 2007). Enrichment of H3K27ac at the start sites for Gad1
(p < 0.05) andGad2 (p = 0.08) suggested enhanced transcription
of these genes (Figure 4E). Consequently, Gad1 and Gad2 may
have been upregulated in surviving GABAergic neurons without
fully compensating for the effects of neurodegeneration. Other
histone modifications appeared to reflect less specific changes
in the dorsal horn transcriptome as they were also found at pro-
moter regions of unrelated genes, such as actin (Actb) or activity-
regulated cytoskeletal-associated protein (Arc) (Figure S3).
Eliminating NMDAR Signaling Stops the Transition to
Chronic Neuropathic Pain
Stereotaxic injection of AAV8 into the dorsal horn orGFP expres-
sion alone did not alter nociceptive behavior except for a slightly
longer response to the cooling sensation evoked by acetone
evaporation (Figure S4).
To examine the impact of NMDAR elimination on pain-like
behavior after SNI, we compared the responses to calibrated
von Frey filaments and acetone evaporation in Grin1flox/floxCell Reports 23, 2678–2689, May 29, 2018 2681
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Figure 3. Neuroprotection Preserves Spinal Inhibition
(A) GFP expression in GABAergic dorsal horn neurons ofGad1-GFPmice. SomeGABAergic neurons also produced glycine. Scale bars, 100 mm (large panels) or
10 mm (small panels).
(B) Stereological counts of GABAergic neurons in the L4 dorsal horn of uninjured Gad1-GFP mice and 28 days after SNI (n = 6 mice).
(C) Viaat-Venus mice expressed the fluorescent protein in both GABAergic and glycinergic neurons. Scale bars, 100 mm (large panels) or 10 mm (small panels).
(D) Stereological counts of inhibitory interneurons in laminae III+IV of uninjured Viaat-Venus mice (n = 5) and 28 days after SNI (n = 6).
(E–I) Miniature IPSC recordings.
(E) Representative traces of total mIPSCs in C57BL/6 mice. Bar graphs show current frequency and peak amplitude in uninjured mice (n = 17 neurons) and
2 weeks after SNI (n = 25).
(F) Comparison of total mIPSCs in the spinal cord ofGrin1flox/floxmice injected with AAV8-GFP (n = 8 neurons) or AAV8-GFP-Cre (n = 12). Currents were recorded
2 weeks after SNI.
(G) Frequency and peak amplitude of GABAergic mIPSCs in uninjured C57BL/6 mice (n = 12) and 2 weeks after SNI (n = 12).
(H) GABAergic mIPSCs in Grin1flox/flox mice injected with AAV8-GFP (n = 5) or AAV8-GFP-Cre (n = 4). GABAergic currents were recorded in the presence of
strychnine.
(I) Glycinergic mIPSCs, recorded in the presence of bicuculline, did not differ between uninjured C57BL/6 mice (n = 9) and 2 weeks after SNI (n = 11).
*p < 0.05; **p < 0.01; ***p < 0.001. Student’s t test was used for all comparisons. Error bars indicate SEM. See also Figure S2 and Table S1.mice injected with AAV8-GFP-Cre or AAV8-GFP. Withdrawal re-
sponses in both groups of mice increased within 7 days (p <
0.001 compared to sham-operated mice), equivalent to the
development of mechanical and cold allodynia in patients with
neuropathic pain (Figure 5). Cold hypersensitivity after SNI
was initially higher in mice lacking Grin1 (p < 0.05 compared to
Grin1flox/flox mice injected with AAV8-GFP). However, the re-
sponses of Grin1flox/flox mice injected with AAV8-GFP-Cre to
both mechanical and cold stimulation returned to pre-injury
levels, whereas neuropathic-pain-like behavior in mice with
intact NMDARs persisted throughout the testing period of
8 weeks. Interestingly, the time to full recovery differed between
stimulation modalities. Mechanical pain hypersensitivity in
Grin1flox/flox mice injected with AAV8-GFP-Cre was completely
reversed 3 weeks after SNI (p < 0.001; Figures 5A and 5B).
Four weeks later, the mice no longer exhibited pain-like re-
sponses to cold stimulation (p < 0.01; Figures 5C and 5D).2682 Cell Reports 23, 2678–2689, May 29, 2018Spinal Disinhibition and Neuropathic Pain Are
Attenuated in Bax-Deficient Mice
Increased Ca2+ entry in response to NMDAR activation may
trigger neuron death through the intrinsic apoptosis pathway.
To test the role of this pathway for the loss of spinal inhibition
and chronic pain after nerve injury, we used mice with a consti-
tutive deletion ofBax (Knudson et al., 1995). Bax is one of the key
proteins involved in intrinsic apoptosis and regulates the distri-
bution of Ca2+ between cytosol and endoplasmic reticulum
(D’Orsi et al., 2015).
Apoptosis after SNI was almost completely blocked in Bax-
deficient mice (Bax/) (p < 0.001; Figure 6A). Miniature IPSCs
in uninjured Bax/ mice were less frequent and had a lower
amplitude compared to C57BL/6 mice but did not differ from
wild-type mice (Bax+/+). After SNI, the frequency of total and
GABAergic mIPSCs decreased by 64% (p < 0.05) and 56%




Figure 4. Surviving Neurons Maintain the
Expression of Gad, Glyt2, and Viaat
(A–D) Transcript and protein levels of (A) Gad1, (B)
Gad2, (C) Glyt2 (Slc6a5), and (D) Viaat (Slc32a1)
were unchanged in the L4 dorsal horn of mice
28 days after SNI (n = 3 or 4 biological replicates).
qPCR results are presented as mean fold change
of DCT ± SD after normalization to Gapdh and
protein levels as mean fold change ± SEM after
normalization to b3-tubulin (Tubb3). Images show
representative western blot results.
(E) ChIP analysis of H3K27ac at the promoter re-
gions for Gad1, Gad2, Actb, and Arc (n = 4). His-
tone modifications 28 days after SNI are shown,
compared to uninjured mice.
*p < 0.05. Student’s t test was used for all com-
parisons. Error bars indicate SEM. See also Fig-
ure S3 and Table S2.inhibition in C57BL/6 mice (Figures 6B and 6C). In contrast, syn-
aptic inhibition in Bax/mice remained intact (p < 0.01 for total
mIPSCs and p < 0.05 for GABAergic currents compared to
Bax+/+ mice; Figures 6B and 6C).
Nociceptive behavior of Bax/ and Bax+/+ mice at baseline
did not differ. However, painful hypersensitivity to mechanical
(Figures 7A and 7B) or cold stimulation (Figures 7C and 7D)
following SNI was mitigated in Bax/ mice (p < 0.001 in a
two-way ANOVA). This reduced neuropathic-pain-like behavior
was observed throughout the testing period of 8 weeks. Taken
together, the involvement of proapoptotic Bax in spinal disinhibi-
tion and persistent pain after SNI provided additional evidence of
neurodegeneration contributing to chronic neuropathic pain
(Figure S5).
DISCUSSION
Targeted deletion of functional NMDARs protected against the
nerve-injury-induced loss of dorsal horn neurons, suggesting
strongly that glutamate excitotoxicity caused the degeneration
of these cells. Eliminating NMDAR-dependent transmission at
dorsal horn synapses had surprisingly little impact on physiolog-
ical nociception or the onset of pain hypersensitivity after SNI but
disrupted the transition to chronic neuropathic pain. Mechanical
and cold allodynia in mice lacking functional NMDARs began to
resolve one week after the nerve lesion, whereas pain hypersen-
sitivity in mice with intact glutamatergic transmission persistedCell Rfor the entire testing period of 2 months.
These findings suggest that NMDAR acti-
vation plays a fundamentally different role
in neuropathic compared to inflammatory
pain. Footpad injections of inflammatory
irritants, such as capsaicin or formalin,
produce NMDAR-dependent central
sensitization to nociceptive stimuli within
minutes (South et al., 2003), whereas
NMDAR activity in the dorsal horn is not
required for the maintenance of inflam-
matory pain (Weyerbacher et al., 2010).Nerve-injury-induced cell death is likely to involve both inhibitory
and excitatory dorsal horn neurons. Here, we show that the
degeneration of GABAergic neurons hasmajor functional conse-
quences. Neuroprotective NMDAR elimination prevented the
loss of GABAergic mIPSCs and chronic pain after SNI. A consti-
tutive deletion of proapoptotic Bax provided a similar safeguard
against nerve-injury-induced disinhibition and attenuated pain-
like behavior, supporting the conclusion that neurodegeneration
promotes persistent neuropathic pain by weakening the inhibi-
tory control of nociceptive signal transmission in the superficial
dorsal horn of the spinal cord.
NMDAR activation requires depolarization of the cell mem-
brane to release a voltage-dependent Mg2+ block from the recep-
tor ion channel. Enhanced nociceptive input and ectopically
generated activity in injured and neighboring intact nerve fibers in-
crease the recruitment of NMDARs at dorsal horn synapses (Ku-
ner, 2010; Latremoliere and Woolf, 2009). An excitotoxic chal-
lenge may result directly from heightened glutamate release by
primary afferents (Amir et al., 2005; Wu et al., 2001) or follow
the activation of excitatory interneuron circuits within the dorsal
horn (Cheng et al., 2017; Peirs et al., 2015; Duan et al., 2014; Lu
et al., 2013). Insufficient glutamate uptake and presynaptic facili-
tation of transmitter release further increase the risk of glutamate
accumulation after nerve injury (Yan et al., 2013; Inquimbert et al.,
2012). Even a moderate buildup of glutamate may cause neuro-
degeneration through the activation of extrasynaptic NMDARs
(Bao et al., 2009; Hardingham et al., 2002). Ultimately, excitotoxiceports 23, 2678–2689, May 29, 2018 2683
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Figure 5. Eliminating Functional NMDARs in the Dorsal Horn Blocks the Transition from Acute to Chronic Neuropathic Pain
(A and C) Withdrawal responses to (A) mechanical (von Frey filaments) or (C) cold stimulation (acetone evaporation) after sham surgery (n = 7 mice) or SNI (n = 10)
in Grin1flox/floxmice injected with AAV8-GFP-Cre, and SNI in Grin1flox/floxmice injected with AAV8-GFP (n = 10). Behavioral outcomes were compared using two-
way ANOVAs. p < 0.001 for treatment and time in the responses to stimulation with von Frey filaments; p < 0.01 for treatment and p < 0.001 for time in the acetone
test. Asterisks and pound signs indicate the results of Bonferroni’s tests following the ANOVAs.
(B and D) Areas under the curve (AUCs) were first compared for the total test duration after SNI (p < 0.001 for Frey filaments, B, and acetone test, D, in one-way
ANOVAs). Separately, we compared AUCs in the acute phase of the first 7 days after SNI (p < 0.001 for both test modalities), during the transition from acute to
persistent pain (p < 0.001 for the stimulation with von Frey filaments and p < 0.05 for the acetone test), and for persistent pain after 21 or 49 days, respectively (p <
0.001 for von Frey filaments and p < 0.01 for the acetone test). Asterisks and pound signs indicate the results of Tukey’s tests following the ANOVAs.
*p < 0.05, **p < 0.01, and ***p < 0.001 for the comparison of AAV8-GFP-Cre + SNI and AAV8-GFP + SNI; #p < 0.05, ##p < 0.01, and ###p < 0.001 for the comparison
of AAV8-GFP-Cre + Sham and AAV8-GFP-Cre + SNI. Error bars indicate SEM. See also Figure S4.cell death is triggered by excessCa2+ influx throughNMDARsand
subsequent activation of neuronal nitric oxide synthase (Hara and
Snyder, 2007). Our results indicate a downstream engagement of
the intrinsic apoptotic pathway, which involves mitochondrial
translocation of Bax or Bcl2-antagonist killer 1 (Bak1) followed
by cytochrome c release into the cytoplasm and caspase activa-
tion (Youle and Strasser, 2008). Bax may further promote excito-
toxicity by regulating the Ca2+ exchange between cytosol and
endoplasmic reticulum (D’Orsi et al., 2015).
Spatially restricted elimination of NMDAR-mediated transmis-
sion was necessary to clarify the functional significance of gluta-
mate-induced neurodegeneration in the dorsal horn. NMDARs
are expressed at excitatory synapses throughout the CNS. Phar-
macological studies based on the use of NMDAR antagonists
cannot distinguish between analgesic effects achieved by block-
ing postsynaptic receptors in spinal or supraspinal pathways
involved in the processing of pain or by inhibiting presynaptic re-
ceptors at the central terminals of primary afferents (Yan et al.,
2013; Suzuki et al., 2002). Interpreting pain-like behavior in
mice treated with NMDAR antagonists is further complicated2684 Cell Reports 23, 2678–2689, May 29, 2018by motor side effects and the attenuation of stress, fear, and
depression. Targeted Grin1 deletion in dorsal horn neurons
enabled us to reveal the role of neurodegeneration in the spinal
cord for the transition from acute to chronic neuropathic pain.
Pain after nerve injury appeared to evolve in three phases. (1)
In the acute period of approximately 7 days, hypersensitivity to
mechanical and thermal stimulation emerged independently of
NMDAR expression. The initial increase in pain sensitivity must
therefore be mediated primarily by glutamate signaling through
AMPARs and group I mGluRs or signaling pathways involving
peptide transmitters. In mice with intact NMDARs, withdrawal
responses remained high as previously described (Decosterd
and Woolf, 2000). (2) In the absence of NMDAR-mediated gluta-
matergic transmission, pain sensitivity returned to baseline
levels within 3–7 weeks, demonstrating that NMDAR activity is
required for the establishment of persistent neuropathic pain.
The time to complete recovery may delineate the period during
which neuropathic pain normally progresses to (3) the final phase
of chronic pain. It is unclear why this transition period differed for
mechanical and cold allodynia. One possible explanation is the
A B
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Figure 6. Mice Lacking Proapoptotic Bax
Are Protected against Nerve-Injury-Induced
Disinhibition
(A) Apoptotic profiles in Bax+/+ and Bax/ mice
7 days after SNI (n = 6).
(B) Representative recordings of total mIPSCs. Bar
graphs below show current frequency and peak
amplitude in uninjured Bax+/+ mice and Bax+/+
mice 2 weeks after SNI (n = 18 neurons) and in
uninjured Bax/ mice (n = 13) and Bax/ mice
2 weeks after SNI (n = 19).
(C) GABAergic mIPSCs in uninjured Bax+/+ mice
(n = 11) and Bax+/+ mice 2 weeks after SNI (n = 14)
and in uninjured Bax/ mice (n = 8) and Bax/
mice 2 weeks after SNI (n = 9).
*p < 0.05 and ***p < 0.001 in Student’s t tests
comparing uninjured Bax+/+ mice and Bax+/+ mice
after SNI; #p < 0.05, ##p < 0.01, and ###p < 0.001
for the comparison between Bax+/+ and Bax/
mice after SNI. Error bars indicate SEM. See also
Figure S5.high proportion of cold-sensitive C fiber afferents with increased
activity after nerve injury, which may slow the resolution of cold-
evoked pain (Ja¨nig et al., 2009; Wu et al., 2001). Loss of
GABAergic neurons in laminae I+II will directly affect the inhibi-
tory control of input from these afferents (Peirs and Seal,
2016). In contrast, the survival of inhibitory neurons in laminae
III+IV may facilitate the recovery of normal thresholds for me-
chanically evoked pain, because these interneurons control
polysynaptic connections between touch-sensitive A fiber affer-
ents and neurons in lamina I that convey nociceptive input to the
brain (Cui et al., 2016; Foster et al., 2015; Petitjean et al., 2015;
Duan et al., 2014; Lu et al., 2013). It should be noted that NMDAR
deletion may have interfered with mechanisms unrelated to neu-
rodegeneration, for example, synaptic plasticity. This would offer
one explanation for the difference between the behavioral phe-
notypes of Grin1flox/flox mice lacking functional NMDARs and
Bax/ mice. Alternatively, Bax-independent cell death path-
ways may be responsible for the incomplete prevention of
persistent pain-like behavior in Bax/mice (Youle and Strasser,
2008).
The anatomical distribution of nerve-injury-induced neurode-
generation suggests differences in the risk of NMDAR-mediated
cell death. Apoptosis induction was concentrated in the medial
dorsal horn, which receives afferent input from the injured sciatic
nerve branches (Corder et al., 2010). Furthermore, a larger pro-
portion of neurons (25%) were lost in the superficial dorsal
horn compared to laminae III+IV (14%). Laminae I+II receiveCell Rafferent input from nociceptive C and Ad
nerve fibers. Ectopic activity in these
nerve fibers is common after nerve injury
(Ja¨nig et al., 2009; Wu et al., 2001). More-
over, non-nociceptive Ab fibers gain ac-
cess to superficial dorsal horn layers as
normally suppressed polysynaptic path-
ways open (Cheng et al., 2017; Peirs
et al., 2015; Duan et al., 2014; Lu et al.,
2013). This additional input involvesNMDAR activation, heightening the risk of glutamate toxicity
(Torsney and MacDermott, 2006). A lower exposure of inhibitory
neurons in laminae III and deeper to such increases in glutama-
tergic input may explain the preserved integrity of glycinergic in-
hibition. Neurons releasing glycine, either in conjunction with
GABA or as their sole neurotransmitter, reside in this region of
the dorsal horn. Their number did not decline after SNI (Lu
et al., 2013; Zeilhofer et al., 2005). Our findings correspond to
the recently reported survival of parvalbumin-expressing inhibi-
tory neurons at the border between inner lamina II and III (Petit-
jean et al., 2015) and the pattern of neurodegeneration in the dor-
sal horn observed after spinal nerve ligation (Yowtak et al., 2013).
Similar to immunohistochemical studies of the rat dorsal horn
(Todd, 2010), we identified 35% of neurons in laminae I+II and
40% in laminae III+IV of uninjured mice as inhibitory neurons
based on the expression of fluorescent reporter proteins under
the Gad1 or Viaat promoter. Degeneration of these important
gatekeepers of nociceptive pathways has substantial functional
consequences, as the decrease in inhibitory currents after SNI
demonstrates. It is not too surprising that the reduction of
mIPSCs was proportionally larger than the loss of GABAergic
neurons. Stereological neuron counts do not reflect the extent
of changes in synaptic connections or their functional implica-
tions. They do not reveal the decay of dendrites, dendritic
spines, or axon terminals associated with neurodegeneration
(Lorenzo et al., 2014; Bao et al., 2009). Moreover, excess gluta-
mate may have impaired the functioning of surviving neurons.eports 23, 2678–2689, May 29, 2018 2685
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Figure 7. Disrupting the Intrinsic Apoptotic Pathway Reduces
Neuropathic-Pain-like Behavior
(A and C) Withdrawal responses to (A) mechanical (von Frey filaments) or (C)
cold stimulation (acetone evaporation) after SNI (n = 9). p < 0.001 for genotype
and p < 0.05 for timewhen responses to the stimulation with von Frey filaments
were compared in a two-way ANOVA. p < 0.001 for both genotype and time in
the acetone test. Pound signs indicate the results of Bonferroni’s tests
following the ANOVAs.
(B and D) AUCs for the withdrawal responses to (B) mechanical or (D) cold
stimulation were compared for the total test duration after SNI. Pound signs
indicate the results of Student’s t tests.
#p < 0.05, ##p < 0.01, and ###p < 0.001 in Student’s t tests. Error bars
indicate SEM.The neuroprotective effect of a-phenyl-N-tert-butylnitrone, a
compound that traps free radical species and inhibits their syn-
thesis, suggests that oxidative stress is one consequence of
NMDAR-mediated excitotoxicity in the dorsal horn (Yowtak
et al., 2013). Other mechanisms are likely to contribute to the
decrease in synaptic inhibition after nerve injury. Brain-derived
neurotrophic factor (Bdnf) released from microglia provokes
downregulation of K+-Cl cotransporter 2 (KCC2). Reduced
KCC2 expression, phosphorylation, and cleavage of the trans-
porter by the Ca2+-dependent protease calpain lead to a rise in
intracellular Cl that weakens the hyperpolarizing efficacy of
GABAA receptor activation (Kahle et al., 2016; Zhou et al.,
2012; Coull et al., 2005). The functional significance of these
mechanisms changes with time. Microglial activity, for example,
is high during the onset of neuropathic pain. Consequently,
KCC2 regulation by Bdnf is probably less relevant for chronic
pain (Peng et al., 2016). In contrast, the NMDAR-dependent
degeneration of GABAergic neurons contributes specifically to
the persistence of neuropathic pain.
We conclude that chronic neuropathic pain resembles, in a
key aspect of its pathophysiology, a neurodegenerative disor-
der. Cell death induction after nerve injury appears to be a pro-
tracted process in which a relatively low level of apoptosis leads
to a sizable decrease in the number of dorsal horn neurons over
time. This slow progression is comparable to neurodegeneration
in other diseases associated with chronic glutamate toxicity,2686 Cell Reports 23, 2678–2689, May 29, 2018such as amyotrophic lateral sclerosis (Lewerenz and Maher,
2015). The irreversible loss of GABAergic neurons causes a ma-
jor shift in the normally carefully regulated balance between
inhibitory and excitatory modulation of pain processing. This
long-term deficit in the control of nociceptive signaling is likely
to contribute to the difficulty of treating neuropathic pain.
On the other hand, neuroprotection, which we accomplished
through targeted elimination of NMDAR-mediated glutamatergic
transmission and deletion of proapoptotic Bax, may provide an
opportunity for the prevention of chronic pain. Mechanism-
based treatment approaches for neuropathic pain are urgently
needed (Colloca et al., 2017). Our findings strengthen the ratio-
nale for strategies aiming to restore GABAergic inhibition
through gene transfer (Hao et al., 2005) or the transplantation
of GABAergic neuron precursors (Bra´z et al., 2012).
EXPERIMENTAL PROCEDURES
In compliance with the Animal Research: Reporting of In Vivo Experiments
(ARRIVE) guidelines, mice were randomly allocated to the experimental condi-
tions and investigators blind to the allocation. A detailed description of the
Experimental Procedures is provided in the Supplemental Information.
Animals
This study was conducted in accordance with the NIH Guide for the Care and
Use of Laboratory Animals and approved by the Institutional Animal Care and
Use Committees (IACUCs) of Columbia University and Boston Children’s
Hospital.
Experiments were performed with male adult (8–12 weeks old) animals.
C57BL/6 and Bax/ mice (Knudson et al., 1995) were purchased from Jack-
son Laboratory. Grin1flox/flox, Gad1-GFP, and Viaat-Venus mice have been
described (Wang et al., 2009; Tamamaki et al., 2003; Tsien et al., 1996).
Surgery
For SNI, we ligated and transected the common peroneal and tibial branches
of the sciatic nerve (Decosterd and Woolf, 2000). Mice received 2 unilateral
(left) stereotaxic injections of AAV8 vectors expressing GFP or GFP-Cre into
the dorsal horn, cranial, and caudal of spinal cord segment L4, as previously
described (Inquimbert et al., 2013).
TUNEL Assay
We used ApopTag In Situ Apoptosis Detection Kits (EMDMillipore) for TUNEL
on cryosections (10 mm) of the dorsal horn. Only profiles exhibiting chromatin
changes indicative of apoptosis (pyknosis, fragmentation, andmarginalization)
were counted.
Stereology
For the stereological analysis of total neurons, we cut transverse cryosections
(50 mm) of the spinal cord. From a random start, we selected every 4th section
and stained them for NeuN (EMD Millipore). Neurons were counted in laminae
I+II and laminae III+IV of the medial half of the dorsal horn. Dorsal and ventral
boundaries of these regions of interest (ROIs) were defined based on cytoarch-
itecture. The number of neurons was determined using the optical fractionator
(West et al., 1991), with counting spaces distributed in a systematic-random
fashion (Table S1). The analysis was performed with Stereo Investigator soft-
ware (MBF Bioscience).
Inhibitory neurons expressing GFP or Venus were counted in sections of
30-mm thickness. We selected every 5th section and immunostained
them for NeuN and the g isoform of protein kinase C (PKCg) (Santa Cruz
Biotechnology), using fluorescently labeled secondary antibodies for detec-
tion. We delineated the same ROIs as for the counts of total neurons based
on cytoarchitecture and PKCg expression, which demarcates the boundary
between laminae II and III (Table S1).
qPCR
RNA was purified from the ipsilateral dorsal quadrants of the L4 spinal
cord. qPCR was performed with a SYBR Select Master Mix (Thermo
Fisher Scientific) except for Glyt2 (Slc6a5). For Slc6a5, we utilized a TaqMan
Universal Mastermix II (Thermo Fisher Scientific) and FAM dye-labeled minor
groove-binding (MGB) probes. Targets were normalized to glyceraldehyde-3-
phosphate dehydrogenase (Gapdh). Table S2 lists the forward and reverse
primers. All reactions were performed on a StepOnePlus System (Thermo
Fisher Scientific).
ChIP
For ChIP assays, we combined the left (ipsilateral) dorsal quadrants of the L4
spinal cord of two mice into one sample. ChIP was performed as previously
described (Korb et al., 2015). Three technical replicates were averaged for
each biologically independent sample and DNA levels normalized to input.
Table S2 lists the forward and reverse primers.
In Situ Hybridization
Riboprobes of 911 bp length were generated from aGrin1 cDNA template and
labeled with digoxigenin (Roche Life Science). Probes bound to spinal cord
cryosections (10 mm) were immunostained with antigen-binding fragments
(Fabs) conjugated to alkaline phosphatase (Roche Life Science). Probes in
sense orientation served as negative controls.
Electrophysiology
Recordings were performed on acute spinal cord slices as described (Inquim-
bert et al., 2012; Tong and MacDermott, 2014). We obtained voltage-clamp
whole-cell patch recordings fromdorsal horn neurons in lamina II and the border
between laminae II and III. We recorded mIPSCs at a holding potential of
70 mV in the presence of 0.5 mM tetrodotoxin (TTX) and ionotropic glutamate
receptor blockers, either 2 mM kynurenic acid or 50 mMD-2-amino-5-phospho-
novalerate (AP5) and 10 mM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]qui-
noxaline-7-sulfonamide (NBQX). To isolate GABAergic or glycinergic currents,
we used 1 mM strychnine HCl or 10 mM bicuculline methiodide, respectively.
Miniature EPSCs were recorded at 70 mV in the presence of 0.5 mM TTX,
1 mM strychnine, and 10 mM bicuculline. Currents evoked by 100 mM NMDA
were recorded at +40 mV in the presence of 25 mMNBQX.We used pClamp10
software (Molecular Devices) for data acquisition and Mini Analysis software
(Synaptosoft) or the Win EDR and Win WCP programs of Strathclyde Electro-
physiology Software for analysis.
Behavioral Tests
All behavioral evaluations were replicated in two independent groups of
animals. We applied calibrated von Frey filaments in the territory of the spared
sural nerve to determine the mechanical withdrawal threshold. To test for cold
sensitivity, we recorded the withdrawal duration after applying a drop of
acetone to the skin, which produces a cool sensation upon evaporation
(Inquimbert et al., 2012). Technical details of the tests for mechanical hyperal-
gesia and heat-induced pain are provided in the Supplemental Experimental
Procedures.
Statistics
We used an unpaired two-sided Student’s t test for comparing two experi-
mental conditions, a one-way ANOVA followed by Dunnett’s or Tukey’s test
for comparing more than two conditions, and a two-way ANOVA followed by
Sidak’s or Bonferroni’s test for comparing experimental conditions over
time. We utilized Prism software (GraphPad) for these tests. Sample sizes pro-
videdR90%power for statistically significant results at a = 0.05, as calculated
with G*Power software (Heinrich Heine University D€usseldorf). Unless other-
wise mentioned, data are represented as mean ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at
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